Open AccessRNA splicing mutation in an aberrantly rearranged immunoglobulin lambda I gene.
Author(s) -
Nobumichi Hozumi,
Gillian E. Wu,
Helios Murialdo,
Larry E. Roberts,
Dan Vetter,
Wendy L. Fife,
Mary Whiteley,
Paul D. Sadowski
Publication year - 1981
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.78.11.7019
Subject(s) - microbiology and biotechnology , biology , point mutation , intron , gene , rna splicing , gene rearrangement , rna , mutation , genetics
The mouse cell line MOPC 315 is an IgA (lambda II)-producing myeloma. We have studied a derivative of MOPC 315 that secretes normal lambda II chains but no heavy chain. This derivative, MOPC 315-26, was found to contain a rearranged lambda I gene in addition to a rearranged lambda II gene. The rearranged lambda I gene was cloned into bacteriophage lambda DNA and its structure was studied. The lambda I gene was found to have arisen by an aberrant recombination event that resulted in a single base insertion at the site of V-J region joining. In addition, the gene contained numerous point mutations in the vicinity of the junction of the V and J regions. Two point mutations occurred in the donor splice sequence normally used for the removal of the intron between the J and C regions, suggesting that the RNA synthesized from the aberrantly rearranged lambda I gene would be unable to undergo proper RNA splicing.